Bottom line
ETHSX vs SHSSX: the short answer
ETHSX (Eaton Vance Worldwide Health Sciences Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
But SHSSX is far broader, holding 155 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
SHSSX is cheaper at 0.86% vs 1.18% — a difference of $32 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +5.3% for ETHSX (reporting dates differ).
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
ETHSX vs SHSSX side by side
| ETHSX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.18% | 0.86% |
| Annual cost per $10k | $118 | $86 |
| 10-yr cost on $10k (prospectus) | $1,911 | $1,061 |
| Max front load | 5.25% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −1.9% | +16.3% |
| 5-yr return (annualized) | +5.3% | +5.9% |
| 10-yr return (annualized) | +6.4% | +9.8% |
| Best quarter | +14.2% | — |
| Worst quarter | −12.1% | — |
| Net assets (fund) | $757.9M | $5.9B |
| Number of holdings | 42 | 155 |
| Portfolio turnover | 3% | 49% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of ETHSX's top 25 holdings also appear in SHSSX's top 25.
| Holding | ETHSX | SHSSX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 12.29% |
| AbbVie Inc | 6.46% | 3.94% |
| Johnson & Johnson | 6.45% | 8.77% |
| AstraZeneca PLC | 6.24% | 1.21% |
| UnitedHealth Group Inc | 5.49% | 6.10% |
| Merck & Co Inc | 5.08% | 4.94% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.74% |
| Gilead Sciences Inc | 3.34% | 4.19% |
| Thermo Fisher Scientific Inc | 2.79% | 3.02% |
| Intuitive Surgical Inc | 2.72% | 1.95% |
| Stryker Corp | 2.21% | 1.15% |
| Boston Scientific Corp | 2.18% | 1.59% |
| Abbott Laboratories | 1.65% | 1.97% |
| Argenx SE | 1.61% | 1.26% |
Source: SEC Form N-PORT
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between ETHSX and SHSSX?
Which is cheaper, ETHSX or SHSSX?
Should I own both ETHSX and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.